Carlyle, the US-based private equity firm, has acquired Tarrytown Expocare Pharmacy, a leading long-term care pharmacy provider in the United States. The acquisition closed on November 14, 2025, with Carlyle using its buy-side financial advisor Wells Fargo to secure the deal from Sheridan Capital Partners.
| Acquirer | Target | Value | Type | Closing Date | Advisors (Buy) | Advisors (Sell) |
|---|---|---|---|---|---|---|
| Carlyle | Tarrytown Expocare Pharmacy | Undisclosed | Acquisition | November 14, 2025 | Wells Fargo | Houlihan Lokey |
Deal Mechanics
Carlyle announced the acquisition of Tarrytown Expocare Pharmacy on November 14, 2025. The transaction was facilitated by Wells Fargo as the buy-side advisor for Carlyle and Houlihan Lokey acting as the sell-side advisor representing Sheridan Capital Partners.
Strategic Rationale
Carlyle's acquisition of Tarrytown Expocare Pharmacy aims to strengthen its presence in the long-term care pharmacy sector. By adding Tarrytown, Carlyle gains access to a portfolio of pharmacies dedicated to serving elderly and disabled populations.
Financial Context
The deal value was not disclosed by either party involved in the transaction. However, given Tarrytown’s market position as one of the key players in long-term care pharmacy services, the acquisition is expected to significantly bolster Carlyle's investment portfolio in the healthcare sector.
Advisors
Carlyle was advised on the deal by Wells Fargo for financial matters. Legal counsel for Carlyle included Debevoise & Plimpton and Bass Berry & Sims. On the sell-side, Sheridan Capital Partners worked with Houlihan Lokey as its advisor. McDermott Will & Schulte and Goodwin Procter provided legal representation to Sheridan.
Outlook
The acquisition of Tarrytown Expocare Pharmacy is anticipated to provide Carlyle with a strategic entry point into the long-term care pharmacy market, complementing its existing healthcare investments. The move comes as private equity firms increasingly focus on sectors that offer stable revenue streams and growth potential.